Cila Therapeutics Inc.

Boston, MA

UEI
QQKHLGP1GFF9
CAGE
8Q1V4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subcontinent Asian (Asian-Indian) American Owned
  • Woman Owned Small Business
  • Minority Owned Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
2 Park Pl #201, Jamaica Plain, MA 02130, USA
Website
cilatx.com
Founded
2018
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Cila Therapeutics Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of CIL-0X: a platform to enhance delivery of inhaled RNA therapeutics to lung cells - project summary… Grant · R43TR005938 National Center for Advancing Translational Sciences $379,948

Quick answers

What is Cila Therapeutics Inc.'s UEI?

Cila Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is QQKHLGP1GFF9.

What is Cila Therapeutics Inc.'s CAGE code?

Cila Therapeutics Inc.'s CAGE code is 8Q1V4.

What is Cila Therapeutics Inc.'s primary NAICS code?

Cila Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Cila Therapeutics Inc. located?

Cila Therapeutics Inc.'s physical address in SAM.gov is 2 Park Pl #201, Jamaica Plain, MA 02130, USA.

Is Cila Therapeutics Inc. registered in SAM.gov?

Yes. Cila Therapeutics Inc.'s SAM.gov registration is active through September 27, 2027.

What is Cila Therapeutics Inc.'s most recent federal award?

Cila Therapeutics Inc.'s most recent federal grant award is Development of CIL-0X: a platform to enhance delivery of inhaled RNA therapeutics to lung cells - project summary… (R43TR005938), from National Center for Advancing Translational Sciences, on August 1, 2025.

On GovTribe

See Cila Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login